Protagonist Therapeutics Inc
XBER:PGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Protagonist Therapeutics Inc
XBER:PGF
|
US |
|
L
|
Leggett & Platt Inc
SWB:LP1
|
US |
Multiples-Based Value
The Multiples-Based Value for
Protagonist Therapeutics Inc (PGF) under the Base Case is 17.23 EUR.
Compared with the current market price of 75 EUR, the stock appears
Overvalued by 77% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.